Бизнес по науке : чему менеджерам стоит научиться у биотехнологов Гордон Байндер, Филип Бэше
By: Гордон Байндер
.
Contributor(s): Филип Бэше.
Publisher: Москва Манн, Иванов и Фербер, c2008Description: viii, 270 p. : ill. ; 22 cm.ISBN: 9785916570052; 9785916570052.Subject(s): Гордон Байндер 1935- | Amgen Inc. -- Management | Biotechnology industries -- United States -- Management | Chief executive officers -- United States -- Biography | Biotechnology -- economics -- Personal Narratives | Biotechnology -- history -- Personal Narratives | History, 20th Century -- Personal Narratives | Industry -- Personal NarrativesDDC classification: 338.7/6151092 | B Online resources: Table of contents only
Contents:
The start of a start-up -- Amgen goes public -- The business of science meets the science of business -- From IPO to EPO in four months -- EPO on trial -- Partnerships made in heaven-- and that other place -- Red hot summer -- Nuclear winter -- How to build a winning team -- How Amgen kept employees committed -- The value of ethics in business -- My failed retirement.
| Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|---|
| Book | SKOLKOVO Library Shelves | Not Tagged | HD9999.B444 A443 2008 (Browse shelf) | Available | 2000003011 |
Total holds: 0
Browsing SKOLKOVO Library Shelves , Shelving location: Shelves Close shelf browser
| HD9999.B443 E85125 Venture capital and the European biotechnology industry / | HD9999.B443 G78 Biotech funding trends : | HD9999.B444 A443 Science lessons : | HD9999.B444 A443 2008 Бизнес по науке : | HD9999.I492 C457 From entrepreneur to infopreneur : | HD9999.L852 K37 The luxury strategy : | HD9999.L852 T46 Deluxe : |
Includes index.
The start of a start-up -- Amgen goes public -- The business of science meets the science of business -- From IPO to EPO in four months -- EPO on trial -- Partnerships made in heaven-- and that other place -- Red hot summer -- Nuclear winter -- How to build a winning team -- How Amgen kept employees committed -- The value of ethics in business -- My failed retirement.
There are no comments for this item.